These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 29042204

  • 1. Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Mehta PA, Sauter S, Zhang X, Davies SM, Wells SI, Myers KC, Panicker G, Unger ER, Butsch Kovacic M.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6712-6719. PubMed ID: 29042204
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
    Robbins HA, Waterboer T, Porras C, Kemp TJ, Pawlita M, Rodriguez AC, Wacholder S, Gonzalez P, Schiller JT, Lowy DR, Esser M, Matys K, Poncelet S, Herrero R, Hildesheim A, Pinto LA, Safaeian M.
    Hum Vaccin Immunother; 2014 Dec 04; 10(10):2965-74. PubMed ID: 25483632
    [Abstract] [Full Text] [Related]

  • 3. In RRP, serologic response to HPV is frequently absent and slow to develop.
    Buchinsky FJ, Ruszkay N, Valentino W, Derkay CS, McClay JE, Bastian RW, Myer CM, Lollar KW, Guris D.
    PLoS One; 2020 Dec 04; 15(3):e0230106. PubMed ID: 32160246
    [Abstract] [Full Text] [Related]

  • 4. Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes.
    Alter BP, Giri N, Pan Y, Savage SA, Pinto LA.
    Vaccine; 2014 Feb 26; 32(10):1169-73. PubMed ID: 24295807
    [Abstract] [Full Text] [Related]

  • 5. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
    Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A, Costa Rican Vaccine Trial Group.
    J Natl Cancer Inst; 2010 Nov 03; 102(21):1653-62. PubMed ID: 20944077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HPV Serology Testing Confirms High HPV Immunisation Coverage in England.
    Mesher D, Stanford E, White J, Findlow J, Warrington R, Das S, Pebody R, Borrow R, Soldan K.
    PLoS One; 2016 Nov 03; 11(3):e0150107. PubMed ID: 26959232
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study.
    Heijstek MW, Scherpenisse M, Groot N, Tacke C, Schepp RM, Buisman AM, Berbers GA, van der Klis FR, Wulffraat NM.
    Ann Rheum Dis; 2014 Aug 03; 73(8):1500-7. PubMed ID: 23723319
    [Abstract] [Full Text] [Related]

  • 13. Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.
    Katzenellenbogen RA, Carter JJ, Stern JE, Butsch Kovacic MS, Mehta PA, Sauter SL, Galloway DA, Winer RL.
    Clin Vaccine Immunol; 2015 Apr 03; 22(4):413-20. PubMed ID: 25651924
    [Abstract] [Full Text] [Related]

  • 14. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R, Gravitt PE, Bossis I, Stern PL, Viscidi RP, Roden RB.
    Cancer Res; 2006 Dec 01; 66(23):11120-4. PubMed ID: 17145854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.
    Baisley K, Kemp TJ, Mugo NR, Whitworth H, Onono MA, Njoroge B, Indangasi J, Bukusi EA, Prabhu PR, Mutani P, Galloway DA, Mwanzalime D, Kapiga S, Lacey CJ, Hayes RJ, Changalucha J, Pinto LA, Barnabas RV, Watson-Jones D.
    Lancet Glob Health; 2024 Mar 01; 12(3):e491-e499. PubMed ID: 38365419
    [Abstract] [Full Text] [Related]

  • 17. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
    Ng K, Morais S, Wissing MD, Burchell AN, Tellier P-P, Coutlée F, Waterboer T, El-Zein M, Franco EL.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0022924. PubMed ID: 38687066
    [Abstract] [Full Text] [Related]

  • 18. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
    Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Lu S, Vuocolo S, Hesley TM, Haupt RM, Barr E.
    Vaccine; 2008 Dec 09; 26(52):6844-51. PubMed ID: 18930097
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Vaccination against HPV in adults].
    Gil Á.
    Rev Esp Quimioter; 2009 Nov 09; 22 Suppl 1():22-5. PubMed ID: 20084345
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.